Link selects validated cancer targets and novel target combinations to build on existing knowledge in creating better molecules. Our strength as a leadership team comes from decades of previous experience and collaboration in both academic and industry environments. At Link, we know that our goal is elusive and that the work we do is not easy, but we are focused and determined to create better therapeutics. We are not alone. Our mission is supported by an outstanding Board of Directors and collaboration with industry-leading partners.